These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973 [TBL] [Abstract][Full Text] [Related]
4. [Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions]. Goldhirsch A; Neuenschwander H; Castiglione M; Senn HJ; Cavalli F Schweiz Med Wochenschr; 1990 Nov; 120(47):1771-83. PubMed ID: 2255883 [TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer. Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831 [No Abstract] [Full Text] [Related]
7. Adjuvant treatment of breast cancer. Akerley WL R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524 [TBL] [Abstract][Full Text] [Related]
9. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview. Lippman ME; Chabner BA NCI Monogr; 1986; (1):5-10. PubMed ID: 3534591 [No Abstract] [Full Text] [Related]
10. A prognostic table to guide practitioners advising patients on adjuvant systemic therapy in early breast cancer. Stotter A Eur J Surg Oncol; 1999 Aug; 25(4):341-3. PubMed ID: 10419700 [No Abstract] [Full Text] [Related]
12. [Recent advance in adjuvant therapy for breast cancer]. Shimizu C; Watanabe T Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for node-negative breast cancer: a proactive view. Glick JH Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518 [No Abstract] [Full Text] [Related]
14. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group. Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ; Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy in breast cancer. Robert NJ Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732 [TBL] [Abstract][Full Text] [Related]
17. Use of anti-oestrogen Zitazonium (tamoxifen) as adjuvant to cytostatic treatment in metastatic breast cancer. Palka I; Jávor J Ther Hung; 1986; 34(4):217-23. PubMed ID: 3449976 [No Abstract] [Full Text] [Related]
18. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic therapy in primary breast cancer. Mouridsen HT; Palshof T Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664 [No Abstract] [Full Text] [Related]
20. [Neoadjuvant chemotherapy of patients with breast carcinoma]. Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]